- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Genexine Inc (095700)
Genexine Inc stock price live, this page displays KQ 095700 stock exchange data. View the 095700 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Genexine Inc real time stock price chart below.
What Is the Genexine Inc Stock Price Today?
The Genexine Inc stock price today is 6,730.
What Is the Stock Symbol for Genexine Inc?
The stock symbol for Genexine Inc is "095700."
What Stock Exchange Does Genexine Inc Trade On?
Genexine Inc is listed and trades on the KOSDAQ stock exchange.
Is Genexine Inc a Good Stock to Buy?
Determining whether Genexine Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 095700 quote. (ISIN: KR7095700001)
What Is the Genexine Inc Stock Price Today?
The Genexine Inc stock price today is 6,730.
What Is the Stock Symbol for Genexine Inc?
The stock symbol for Genexine Inc is "095700."
What Stock Exchange Does Genexine Inc Trade On?
Genexine Inc is listed and trades on the KOSDAQ stock exchange.
Is Genexine Inc a Good Stock to Buy?
Determining whether Genexine Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 095700 quote. (ISIN: KR7095700001)
KOSDAQ
Currency in KRW
6,730
-370(-5.21%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6,470
7,190
52 wk Range
4,220
7,490
095700 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6,4707,190
52 wk Range
4,2207,490
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
095700 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy
Genexine, Inc., together with its subsidiaries, operates as a biotechnology company that focuses on the development and commercialization of immunotherapies in South Korea and internationally. The company develops its products through its hybrid Fc platform, a proprietary technology designed to develop long-acting protein drugs; and the DNA vaccine platform that is used to elicit immune responses in the human body to fight viral infection and cancer cells. Its product pipeline includes GX-H9, which is in Phase II and III clinical trials for the treatment of adult and pediatric growth hormone deficiency; GX-E4 that is in Phase III clinical trials for the treatment of anemia; GX-G3, which is in Phase II clinical trials to treat neutropenia; GX-I7, a product candidate in Phase I and II clinical trials to treat solid tumors, lymphopenia, and COVID-19; GX-P1, which is in Phase I clinical trials for the treatment of autoimmune diseases and transplantation; and GX-G6 that is in Phase II clinical trials for the treatment of diabetes. The company is also developing GX-188E that is in Phase II clinical trials for the treatment of cervical cancer, and head and neck cancer. The company was formerly known as Genexine Co., Ltd. and changed its name to Genexine, Inc. in March 2013. Genexine, Inc. was founded in 1999 and is headquartered in Seoul, South Korea.
Compare 095700 to Peers and Sector
Metrics to compare | 095700 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship095700PeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −4.6x | −0.5x | |
PEG Ratio | 0.00 | 0.11 | 0.00 | |
Price/Book | 0.0x | 2.7x | 2.6x | |
Price / LTM Sales | 0.0x | 14.0x | 3.2x | |
Upside (Analyst Target) | 0.0% | 14.9% | 44.2% | |
Fair Value Upside | Unlock | 4.0% | 5.5% | Unlock |
Earnings
Latest Release
Mar 18, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Genexine (095700) Stock Price Today?
The Genexine stock price today is 6,730 KRW.
What Stock Exchange Does Genexine Trade On?
Genexine is listed and trades on the KOSDAQ.
What Is the Stock Symbol for Genexine?
The stock symbol for Genexine is "095700."
What Is the Genexine Market Cap?
As of today, Genexine market cap is 322.91B KRW.
What Is Genexine's Earnings Per Share (TTM)?
The Genexine EPS (TTM) is -1,321.
When Is the Next Genexine Earnings Date?
Genexine will release its next earnings report on May 18, 2026.
From a Technical Analysis Perspective, Is 095700 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Genexine Stock Split?
Genexine has split 2 times.
How Many Employees Does Genexine Have?
Genexine has 86 employees.
What is the current trading status of Genexine (095700)?
As of Apr 20, 2026, Genexine (095700) is trading at a price of 6,730 KRW, with a previous close of 7,100 KRW. The stock has fluctuated within a day range of 6,470 KRW to 7,190 KRW, while its 52-week range spans from 4,220 KRW to 7,490 KRW.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.